ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Endometrial Cancer

Breast Cancer trials near Nashville, TN, USA:

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Active, not recruiting
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 7 other locations

Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer.The names of the study drugs used in this research ...

Active, not recruiting
Breast Cancer Female
Breast Cancer Metastatic
Drug: Trastuzumab
Drug: Sacituzumab Govitecan

Phase 2

Adrienne G. Waks

Nashville, Tennessee, United States of America and 3 other locations

This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...

Active, not recruiting
Breast Cancer
Drug: Endocrine Therapy
Drug: Tamoxifen

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 10 other locations

This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...

Enrolling
Breast Cancer
Drug: Talazoparib

Phase 2

Mass General Brigham
Mass General Brigham

Nashville, Tennessee, United States and 6 other locations

works in treating HER2-negative (HER2-low or HER2-0) metastatic breast cancer.The names of the study drugs involved in this study a...

Enrolling
Breast Cancer
HER2-low Breast Cancer
Drug: Trastuzumab Deruxtecan
Drug: Datopotamab Deruxtecan

Phase 2

Ana C Garrido-Castro, MD

Nashville, Tennessee, United States and 10 other locations

A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...

Enrolling
Breast Cancer Stage IV
Breast Cancer
Drug: MBQ-167

Phase 1

MBQ Pharma

Nashville, Tennessee, United States and 3 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Active, not recruiting
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 31 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Nashville, Tennessee, United States and 9 other locations

The purpose of this study is to find out the maximum tolerated dose (MTD) and/or recommended dose(s) for expansion (RDEs) of JNJ-101684362 (HLD-0117)...

Enrolling
Metastatic Breast Cancer
Drug: JNJ-101684362 (HLD-0117)

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Nashville, Tennessee, United States of America and 6 other locations

This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...

Enrolling
Breast Cancer
Drug: Avelumab
Drug: Palbociclib

Phase 2

Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine

Nashville, Tennessee, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems